PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12442770

Variable selection using pair-correlation method. Environmental applications.

K Héberger·R Rajkó
View original source ↗Export metadata ↓

Abstract

Pair-correlation method (PCM) has been developed for selecting between two, correlated descriptor variables. PCM utilizes systematic information present in the scatter of QSAR applications. The data are suitably ordered in a 2 x 2 contingency table. Statistical tests are used to discriminate between the descriptor variables. We have developed, adapted, investigated and compared the following test statistics to each other: Conditional Fisher's exact test (CE), McNemar's test (MN), Chi-square test and Williams' t-test (Wt). If a test indicates significant difference between the descriptors, we use the terms superior-inferior or winner-loser for the overwhelming and subordinate descriptors, respectively. If more than two variables are to be compared, the discrimination can be made pair-wise and then the variables have to be ordered. Three ways of ordering have been used: simple ordering (number of wins), ordering according to the differences between wins and losses, and ordering according to probability-weighted differences between wins and losses. The basic algorithm of PCM has been described in this paper, the various selection criteria and the ordering methods were compared on suitable model systems. These case studies involved description of cAMP phospodiesterase inhibition by flavons, toxicity of chlorobenzenes and mutagenic character of aromatic and heteroaromatic amines.

Explore related subjects

3',5'-Cyclic-AMP PhosphodiesterasesAminesChlorobenzenesEnvironmental PollutantsEnzyme InhibitorsFlavonoidsModels, ChemicalStatistics as TopicStructure-Activity RelationshipJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Héberger, R Rajkó. 2002. Variable selection using pair-correlation method. Environmental applications.. https://doi.org/10.1080/10629360290023368

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Functional characterization of the human phosphodiesterase 7A1 promoter.

In this paper, the human phosphodiesterase 7A1 (h PDE7A1 ) promoter region was identified and functionally characterized. Transient transfection experiments indicated that a 2.9 kb fragment of the h PDE7A1 5'-flanking region, to position -2907, has strong promoter activity in Jurkat T-cells. Deletion analysis showed that the proximal region, up to position -988, contains major cis -regulatory elements of the h PDE7A1 promoter. This minimal promoter region contains a regulatory CpG island which is essential for promoter activity. The CpG island contains three potential cAMP-response-element-binding protein (CREB)-binding sites that, as judged by in vivo dimethyl sulphate (DMS) footprinting, are occupied in Jurkat T-cells. Moreover, over-expression of CREB results in increased promoter activity, but, on the other hand, promoter activity decreases when a dominant-negative form of CREB (KCREB) is over-expressed. In vivo DMS footprinting strongly indicates that other transcription factors, such Ets-2, nuclear factor of activated T-cells 1 (NFAT-1) and nuclear factor kappaB (NF-kappaB), might also contribute to the regulation of h PDE7A1 promoter. Finally, h PDE7A1 promoter was found to be induced by treatment with PMA, but not by treatment with dibutyryl cAMP or forskolin. These results provide insights into the factors and mechanisms that regulate expression of the h PDE7A gene.

3',5'-Cyclic-AMP Phosphodiesterases↗
PubMed2003

Substituted 2-pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors.

The synthesis and the phosphodiesterase-4 (PDE4) inhibitory activity of 2-pyridinemethanol derivatives is described. The evaluation of the structure-activity relationship (SAR) in this series of novel PDE4 inhibitors led to the identification of compound 9 which exhibits excellent in vitro activity, desirable pharmacokinetic parameters and good efficacy in animal models of bronchoconstriction.

3',5'-Cyclic-AMP Phosphodiesterases↗
PubMed2003

Type 4A cAMP-specific phosphodiesterase is stored in granules of human neutrophils and eosinophils.

Persistent elevations of cAMP levels are generally accompanied by an inhibition of granulocyte functions. Phosphodiesterases play a critical role in regulating intracellular levels of cAMP. The expression of three isoforms of type 4 cAMP-specific phosphodiesterase (PDE4) in neutrophils suggests diversity of isoform localization and targeting in regulating cell function. The sites of cAMP regulation in granulocytes by the PDE4A isoform were investigated by immunoelectron microscopy. PDE4A was localized uniformly in all granule classes of eosinophils, but was restricted in neutrophils to a subset of myeloperoxidase (MPO)-containing granules that were round or elongated with a central crystalloid core. Granulocytes were stimulated with fMLP to investigate the sites of PDE4A targeting during cell activation. In neutrophils, fMLP induced a rapid (1 min) translocation of granules containing PDE4A to the plasmalemma, where some PDE4A and MPO were exocytosed. In these cells, PDE4A labeling within granules was focal and no longer homogeneous. While immunogold labeling of PDE4A was reduced after fMLP stimulation, staining of MPO-containing granules remained high. Extracellular release of PDE4A was also observed in eosinophils stimulated with fMLP. Morphometry revealed that Au labeling was significantly reduced within 1 min, and that there was a shift in PDE4A localization within eosinophil granules from the crystalline core to the matrix. Fluctuations of cAMP levels and ectoprotein kinase activity with PKA properties occur in blood under normal and pathological conditions. The exclusive localization of PDE4A within granules of neutrophils and eosinophils suggests that PDE4A may function to downregulate cAMP signaling at the cell membrane and/or in the extracellular space at the time of granule release.

3',5'-Cyclic-AMP Phosphodiesterases↗